Search Website
The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials.
COGNO is a member of the Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COSA) and has a close working relationship with the COSA Neuro-Oncology Group. COGNO is funded by Cancer Australia. The group is located at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC), at the University of Sydney. The NHMRC CTC coordinates the trials activity within COGNO.
COGNO's main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.

Are you interested in donating money for COGNO research activities or for other support services? If so, please complete this form and email it back to cogno@ctc.usyd.edu.au
Ideas or Concepts

COGNO is interested in developing new concepts into protocols and translating these into clinical research.

If you have a concept you are interested in developing, please complete this online form.

Recent News

3/10/2017: COGNO ASM Session 6: Research and Oral Abstracts

There are 20 days to go until the COGNO ASM in Melbourne! We all know that the treatment options for patients with brain tumours are not good enough. The hope for better treatments and outcomes lies in the extensive research efforts that are currently underway to tackle this need, both in Australia and internationally...

28/09/2017: COGNO: Notice of AGM

The COGNO Annual General Meeting will be held on Tuesday 24 October 2017, from 5.15pm-5.45pm, in the Broadway Room, Rydges Melbourne, 186 Exhibition Street, Melbourne, VIC 3000. Meeting papers will be circulated shortly.

11/09/2017: COGNO: items of interest (ACTA, COSA, Szent-Gyorgyi Prize)

The following items may be of interest to you...